Related references
Note: Only part of the references are listed.Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress
Melanie Focking et al.
MOLECULAR PSYCHIATRY (2021)
Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study
Joe Kwun Nam Chan et al.
BRITISH JOURNAL OF PSYCHIATRY (2021)
Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19
Stephen M. Smith et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Unique immunological profile in patients with COVID-19
Stefania Varchetta et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study
Guillaume Fond et al.
SCHIZOPHRENIA BULLETIN (2021)
Increased risk ofCOVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States
QuanQiu Wang et al.
WORLD PSYCHIATRY (2021)
Global pandemics interconnected - obesity, impaired metabolic health and COVID-19
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review
Beatriz Oda Plasencia-Garcia et al.
PSYCHOPHARMACOLOGY (2021)
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
Yu Zuo et al.
SCIENTIFIC REPORTS (2021)
Observational study of haloperidol in hospitalized patients with COVID-19
Nicolas Hoertel et al.
PLOS ONE (2021)
The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study
Benjamin I. Perry et al.
PLOS MEDICINE (2021)
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19
Katlyn Nemani et al.
JAMA PSYCHIATRY (2021)
Toxicity of psychotropic drugs in patients with COVID-19: A systematic review
Michel Sabe et al.
GENERAL HOSPITAL PSYCHIATRY (2021)
Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohort
Benjamin I. Perry et al.
SCHIZOPHRENIA RESEARCH (2021)
Are psychiatric disorders risk factors for COVID-19 susceptibility and severity? a two-sample, bidirectional, univariable, and multivariable Mendelian Randomization study
Jurjen J. Luykx et al.
TRANSLATIONAL PSYCHIATRY (2021)
Vitamin D deficiency in schizophrenia implications for COVID-19 infection
D. Viani-Walsh et al.
IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE (2021)
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
Carolyn T. Bramante et al.
LANCET HEALTHY LONGEVITY (2021)
Clinical characteristics, hospital course, and outcomes among COVID-19 positive patients with mental illness in a community hospital in New York City
Oluwole Jegede et al.
INTERNATIONAL JOURNAL OF MENTAL HEALTH (2021)
Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA
Maxime Taquet et al.
LANCET PSYCHIATRY (2021)
Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation
Helen Q. Cai et al.
MOLECULAR PSYCHIATRY (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Annual Prevalence and Incidence of Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A National Health Insurance Data-Based Study
Sung Joon Cho et al.
PSYCHIATRY INVESTIGATION (2020)
Neuroleptic malignant syndrome in a COVID-19 patient
Raahil Kajani et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Obesity Is a Risk Factor for Severe COVID-19 Infection Multiple Potential Mechanisms
Naveed Sattar et al.
CIRCULATION (2020)
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients withCOVID-19
Huiqing Li et al.
DIABETES OBESITY & METABOLISM (2020)
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Wei-jie Guan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders
Nicole Kozloff et al.
SCHIZOPHRENIA BULLETIN (2020)
The impact of COVID-19 on individuals living with serious mental illness
Kareem Hamada et al.
SCHIZOPHRENIA RESEARCH (2020)
Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms
Zhiqiang Zhou et al.
JOURNAL OF NEUROLOGY (2020)
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
Behnood Bikdeli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
Christopher M. Petrilli et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Jean-Francois Llitjos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
The Mental Health Consequences of COVID-19 and Physical Distancing The Need for Prevention and Early Intervention
Sandro Galea et al.
JAMA INTERNAL MEDICINE (2020)
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Ling Mao et al.
JAMA NEUROLOGY (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Vitamin-D and COVID-19: do deficient risk a poorer outcome?
Fiona Mitchell
LANCET DIABETES & ENDOCRINOLOGY (2020)
Viral and host factors related to the clinical outcome of COVID-19
Xiaonan Zhang et al.
NATURE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study
Sufei Wang et al.
DIABETOLOGIA (2020)
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
Giovanni Ostuzzi et al.
BMC MEDICINE (2020)
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Matteo Apicella et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Coagulation abnormalities and thrombosis in patients with COVID-19
Marcel Levi et al.
LANCET HAEMATOLOGY (2020)
COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis
Mohammad Javad Nasiri et al.
FRONTIERS IN MEDICINE (2020)
Central nervous system manifestations of COVID-19: A systematic review
Ali A. Asadi-Pooya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19
Jeffrey S. Berger et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Natural History of Asymptomatic SARS-CoV-2 Infection
Aki Sakurai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19
Peder L. Myhre et al.
CIRCULATION (2020)
Cytokine storm induced by SARS-CoV-2
Peipei Song et al.
CLINICA CHIMICA ACTA (2020)
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries
Michael C. Grant et al.
PLOS ONE (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships
Barry M. Popkin et al.
OBESITY REVIEWS (2020)
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study
Ash K. Clift et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Influence of social isolation caused by coronavirus disease 2019 (COVID-19) on the psychological characteristics of hospitalized schizophrenia patients: a case-control study
Jun Ma et al.
TRANSLATIONAL PSYCHIATRY (2020)
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
Peter A. McCullough et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2020)
Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study
Seung Won Lee et al.
LANCET PSYCHIATRY (2020)
Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis
Mahmoud B. Malas et al.
ECLINICALMEDICINE (2020)
Neuropathobiology of COVID-19: The Role for Glia
Marie-Eve Tremblay et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19
Aining Zhang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk
Meghan May et al.
BRAIN, BEHAVIOR, & IMMUNITY - HEALTH (2020)
Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia A systematic review, meta analysis, and meta-regression
Ian Huang et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study
Wonjun Ji et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform
Yu-Tao Xiang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
Jessica J. Manson et al.
LANCET RHEUMATOLOGY (2020)
Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
Toby Pillinger et al.
MOLECULAR PSYCHIATRY (2019)
Dysglycaemia, Inflammation and Psychosis: Findings From the UK ALSPAC Birth Cohort
Benjamin Ian Perry et al.
SCHIZOPHRENIA BULLETIN (2019)
The changes in immune cell concentration during the progression of pre-diabetes to type 2 diabetes in a high-fat high-carbohydrate diet-induced pre-diabetic rat model
Nomusa Christina Mzimela et al.
AUTOIMMUNITY (2019)
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies
D. Papola et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice
Meghan May et al.
PLOS ONE (2019)
Schizophrenia
Stephen R. Marder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis
Toby Pillinger et al.
SCHIZOPHRENIA BULLETIN (2019)
Abnormal levels of vascular endothelial biomarkers in schizophrenia
Tanya T. Nguyen et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2018)
Blood-Based Protein Changes in Childhood Are Associated With Increased Risk for Later Psychotic Disorder: Evidence From a Nested Case-Control Study of the ALSPAC Longitudinal Birth Cohort
Jane A. English et al.
SCHIZOPHRENIA BULLETIN (2018)
Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence
Anna K. Jonsson et al.
CNS DRUGS (2018)
Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016
Fiona J. Charlson et al.
SCHIZOPHRENIA BULLETIN (2018)
Further evidence for depletion of peripheral blood natural killer cells in patients with schizophrenia: A computational deconvolution study
Pawel Karpinski et al.
SCHIZOPHRENIA RESEARCH (2018)
Prevalence of Comorbid Chronic Obstructive Pulmonary Disease in Individuals Suffering from Schizophrenia and Bipolar Disorder: A Systematic Review
Nicholas Zareifopoulos et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
Christoph U. Correll et al.
WORLD PSYCHIATRY (2017)
Association Between Antipsychotic Agents and Risk of Acute Respiratory Failure in Patients With Chronic Obstructive Pulmonary Disease
Meng-Ting Wang et al.
JAMA PSYCHIATRY (2017)
Impaired Glucose Homeostasis in First-Episode Schizophrenia A Systematic Review and Meta-analysis
Toby Pillinger et al.
JAMA PSYCHIATRY (2017)
Inflammatory Biomarkers and Risk of Schizophrenia A 2-Sample Mendelian Randomization Study
Fernando Pires Hartwig et al.
JAMA PSYCHIATRY (2017)
Plasma GDF15 level is elevated in psychosis and inversely correlated with severity
Parvin Kumar et al.
SCIENTIFIC REPORTS (2017)
Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study
Stephen A. Metcalf et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Microglial activation and progressive brain changes in schizophrenia
L. E. Laskaris et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
Amy R. Cameron et al.
CIRCULATION RESEARCH (2016)
Leukocytosis after Clozapine Treatment in a Patient with Chronic Schizophrenia
Aslihan Polat et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY (2016)
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
Davy Vancampfort et al.
WORLD PSYCHIATRY (2016)
Association of Mental Disorders With Subsequent Chronic Physical Conditions World Mental Health Surveys From 17 Countries
Kate M. Scott et al.
JAMA PSYCHIATRY (2016)
Dysfunction in the coagulation system and schizophrenia
S. Hoirisch-Clapauch et al.
TRANSLATIONAL PSYCHIATRY (2016)
The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis
Benjamin Ian Perry et al.
LANCET PSYCHIATRY (2016)
Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
Vera Grossmann et al.
DIABETES CARE (2015)
The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology
Sun-Young Ahn et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2015)
Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia - significance for activation of the kynurenine pathway
Lilly Schwieler et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2015)
The role of inflammation in schizophrenia
Norbert Mueller et al.
FRONTIERS IN NEUROSCIENCE (2015)
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Golam M. Khandaker et al.
LANCET PSYCHIATRY (2015)
Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies
Corrado Barbui et al.
DRUG SAFETY (2014)
Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
Rachel Upthegrove et al.
SCHIZOPHRENIA RESEARCH (2014)
Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life A Population-Based Longitudinal Study
Golam M. Khandaker et al.
JAMA PSYCHIATRY (2014)
A meta-analysis of cardio-metabolic abnormalities in drug naive, first-episode and multi-episode patients with schizophrenia versus general population controls
Davy Vancampfort et al.
WORLD PSYCHIATRY (2013)
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review
Kyoko Higashi et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2013)
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Brian J. Miller et al.
BIOLOGICAL PSYCHIATRY (2011)
Antipsychotics and Venous Thromboembolism Risk: A Meta-Analysis
R. Zhang et al.
PHARMACOPSYCHIATRY (2011)
Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives
Edgardo Carrizo et al.
SCHIZOPHRENIA RESEARCH (2008)
The cardiovascular and respiratory health of people with schizophrenia
R Filik et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
The poor general health of the severely mentally III: Impact of schizophrenic diagnosis
L Chafetz et al.
COMMUNITY MENTAL HEALTH JOURNAL (2005)
Share Paper
